Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-30 @ 3:10 AM
Study NCT ID:
NCT00920868
Status:
COMPLETED
Last Update Posted:
2016-02-03
First Post:
2009-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
Sponsor:
Organization: